组合鼻喷剂缓解顽固性鼻塞且无反弹性充血副作用
Nasal spray duo offers relief for stubborn blocked noses without rebound congestion in early clinical trial
一项早期临床试验表明,将去氧伪麻黄碱与布地奈德联合使用比单独使用布地奈德更有效,且无反弹性充血副作用。研究结果显示,组合疗法在四周内显著减轻鼻塞症状,且在撤药后仍保持效果。
研究显示新组合疗法在早期临床试验中有效,无反弹性充血副作用。
A blocked nose can make it difficult to sleep and taste food, and it can get really annoying after a while. Nasal decongestant sprays like oxymetazoline can provide relief, but continued use can worsen nasal obstruction by causing irritation and inflammation in the nasal passages. A recent clinical trial was on a mission to find a combination of drugs that can provide lasting relief from chronic nasal blockage without triggering rebound congestion, a type of nasal obstruction that happens when you overuse nasal decongestant sprays.
The new combination treatment included oxymetazoline, a decongestant, and budesonide, a steroid, which researchers tested for seven weeks in patients with long-term chronic nasal obstruction. After four weeks, 83% of participants in the combination group reported at least moderate improvement, compared with 36% who received budesonide alone. Also, none of the patients using the combination spray experienced rebound swelling during this period.
The findings are published in JAMA Otolaryngology–Head & Neck Surgery.
Two-way attack on nasal congestion
When a blocked nose makes breathing difficult, nasal sprays are often among the first things people reach for. Standard steroid nasal sprays fail to provide adequate relief for up to 40% of people with chronic nasal obstruction.
Over-the-counter decongestants such as oxymetazoline can clear a blocked nose almost instantly. By shrinking the blood vessels in the nasal lining, they open up the nasal passages and make breathing easier. However, the relief can come at a cost when the spray is used for too long. It can cause the nasal lining to swell and become inflamed again, triggering a condition called rhinitis medicamentosa, or rebound congestion. The returning blockage can prompt people to use the spray more often or increase their doses for relief, creating dependence.
Previous studies indicated that adding an intranasal corticosteroid protects against this rebound effect. To see whether combining the two drugs could provide lasting relief, researchers enrolled 60 adults with chronic nasal blockage in a double-blind, randomized clinical trial. All had already tried standard steroid nasal sprays without success.
The team then split them into two groups, one receiving the combination spray and the other the corticosteroid budesonide alone. Participants used their assigned sprays twice a day for four weeks, followed by a three-week tapering period. This allowed researchers to see whether gradually withdrawing oxymetazoline would bring back the dreaded rebound congestion.
Combination vs. solo corticosteroid
The combination spray cleared nasal blockage far more effectively than budesonide alone, with patients reporting a 69% reduction in nasal obstruction scores after two weeks, compared with 41% in the budesonide-only group. The gap widened by week four, when congestion levels fell by 76% in the combination group, compared with 46% in the control group.
Over four weeks of daily full-dose oxymetazoline, no one using the combination spray had worse congestion or any sign of rebound swelling. When researchers cut back the oxymetazoline dose in weeks 5 and 6, patients handled the step-down easily without any serious worsening of their condition. Even at week 7, after a full week with no oxymetazoline, no patient's congestion got worse, so they didn't have to reach for the spray. Seventy-five percent of well-controlled patients kept their symptoms under control throughout that washout week.
The results suggest that combining oxymetazoline with budesonide could be an option for stubborn nasal obstruction, though the risk of rebound over the long term can't be ruled out unless long-term trials prove otherwise.
Written for you by our author Sanjukta Mondal, edited by Gaby Clark, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You'll get an ad-free account as a thank-you.
Publication details
Lucas Cruz et al., Nasal Obstruction and Treatment With Oxymetazoline and Corticosteroids, JAMA Otolaryngology–Head & Neck Surgery (2026). DOI: 10.1001/jamaoto.2026.3297
Journal information: JAMA Otolaryngology–Head & Neck Surgery
Who's behind this story?
Sanjukta Mondal
Master's in Chemistry. Freelance science journalist and communicator. Published in Chemistry World, BioSpace, and The Hindu. Full profile →
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
© 2026 Science X Network
Citation: Nasal spray duo offers relief for stubborn blocked noses without rebound congestion in early clinical trial (2026, November 5) retrieved 5 November 2026 from https://medicalxpress.com/news/2026-11-nasal-spray-duo-relief-stubborn.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com